한글목차

개요

혈장 분획 시장은 2023-2028년 100억 달러로 예측되며, 예측 기간 동안 6.09%의 CAGR로 성장할 것으로 예상됩니다.

본 보고서는 혈장 분획 시장의 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등을 정리하여 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은 호흡기 질환 및 AATD를 치료하는 혈장 제품의 보급, 혈장 유래 제품 목록의 증가, 혈장 기반 제품 제조를 위한 M&A의 증가 등에 의해 주도되고 있습니다.

이 보고서는 향후 몇 년 동안 혈장 분획 시장 성장을 주도할 주요 요인으로 노인 인구의 증가와 관련 질환을 꼽았습니다. 또한, 혈장 제품 자급률 향상을 위한 정부 전략과 혈장 채취에 대한 수요 증가가 시장의 큰 수요로 이어질 것으로 보입니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 상황

• 시장 생태계

제3장 시장 규모

• 시장 정의
• 시장 부문 분석
• 시장 규모 2023
• 시장 전망 2023-2028

제4장 시장 규모 실적

• 혈장 분획 세계 시장 2018-2022
• 제품별 부문 분석 2018-2022
• 용도별 부문 분석 2018-2022
• 지역별 부문 분석 2018-2022
• 국가별 부문 분석 2018-2022

제5장 Five Forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 참여업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 상황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 면역글로불린 : 시장 규모와 예측 2023-2028
• 알부민 : 시장 규모와 예측 2023-2028
• 응고인자 농축물 : 시장 규모와 예측 2023-2028
• 프로테아제 억제제 : 시장 규모와 예측 2023-2028
• 기타 : 시장 규모와 예측 2023-2028
• 시장 기회 : 제품별

제7장 시장 세분화 : 용도별

• 시장 부문
• 비교 : 용도별
• 면역학 : 시장 규모와 예측 2023-2028
• 신경내과 : 시장 규모와 예측 2023-2028
• 혈액학 : 시장 규모와 예측 2023-2028
• 구명 구급 : 시장 규모와 예측 2023-2028
• 기타 : 시장 규모와 예측 2023-2028
• 시장 기회 : 용도별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028
• 유럽 : 시장 규모와 예측 2023-2028
• 아시아 : 시장 규모와 예측 2023-2028
• 세계 기타 지역 : 시장 규모와 예측 2023-2028
• 미국 : 시장 규모와 예측 2023-2028
• 중국 : 시장 규모와 예측 2023-2028
• 독일 : 시장 규모와 예측 2023-2028
• 영국 : 시장 규모와 예측 2023-2028
• 일본 : 시장 규모와 예측 2023-2028
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 성장 촉진요인
• 시장 과제
• 성장 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 상황

• 개요
• 벤더 상황
• 혼란 상황
• 업계 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• ADMA Biologics Inc.
• Bharat Serums and Vaccines Ltd.
• CSL Ltd.
• Emergent BioSolutions Inc.
• GC Biopharma corp.
• Grifols SA
• Intas Pharmaceuticals Ltd.
• Kedrion S.p.A
• LFB SA
• Merck KGaA
• Mitsubishi Chemical Group Corp.
• Octapharma AG
• Sanquin
• SK Inc.
• Takeda Pharmaceutical Co. Ltd.

제13장 부록

영문목차

Abstract

The plasma fractionation market is forecasted to grow by USD 10.00 bn during 2023-2028, accelerating at a CAGR of 6.09% during the forecast period. The report on the plasma fractionation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of plasma products treated in respiratory diseases and AATD, a growing list of plasma-derived products, and an increase in M and A for producing plasma-based products.

Technavio's plasma fractionation market is segmented as below:

By Product

• Immunoglobulins
• Albumin
• Coagulation factor concentrates
• Protease inhibitors
• Others

By Application

• Immunology
• Neurology
• Hematology
• Critical care
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing elderly population and related disorders as one of the prime reasons driving the plasma fractionation market growth during the next few years. Also, government strategies for increasing self-sufficiency for plasma products and rising demand for plasma collection will lead to sizable demand in the market.

The report on the plasma fractionation market covers the following areas:

• Plasma fractionation market sizing
• Plasma fractionation market forecast
• Plasma fractionation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma fractionation market vendors that include ADMA Biologics Inc., Bharat Serums and Vaccines Ltd., CSL Ltd., Emergent BioSolutions Inc., GC Biopharma corp. , Grifols SA, Hemarus Plasma, Intas Pharmaceuticals Ltd., Kamada Ltd., Kedrion S.p.A, LFB SA, Merck KGaA, Mitsubishi Chemical Group Corp., Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., Prothya Biosolutions Netherlands BV, Sanquin, SK Inc., Takeda Pharmaceutical Co. Ltd., and Virchow Laboratories Ltd.. Also, the plasma fractionation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global plasma fractionation market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global plasma fractionation market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Application Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Immunoglobulins - Market size and forecast 2023-2028
• Exhibit 34: Chart on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Immunoglobulins - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Immunoglobulins - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Immunoglobulins - Year-over-year growth 2023-2028 (%)
• 6.4 Albumin - Market size and forecast 2023-2028
• Exhibit 38: Chart on Albumin - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Albumin - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Albumin - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Albumin - Year-over-year growth 2023-2028 (%)
• 6.5 Coagulation factor concentrates - Market size and forecast 2023-2028
• Exhibit 42: Chart on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Coagulation factor concentrates - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Coagulation factor concentrates - Year-over-year growth 2023-2028 (%)
• 6.6 Protease inhibitors - Market size and forecast 2023-2028
• Exhibit 46: Chart on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Protease inhibitors - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Protease inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Protease inhibitors - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 56: Chart on Application - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Application - Market share 2023-2028 (%)
• 7.2 Comparison by Application
• Exhibit 58: Chart on Comparison by Application
• Exhibit 59: Data Table on Comparison by Application
• 7.3 Immunology - Market size and forecast 2023-2028
• Exhibit 60: Chart on Immunology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Immunology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Immunology - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Immunology - Year-over-year growth 2023-2028 (%)
• 7.4 Neurology - Market size and forecast 2023-2028
• Exhibit 64: Chart on Neurology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Neurology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Neurology - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
• 7.5 Hematology - Market size and forecast 2023-2028
• Exhibit 68: Chart on Hematology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Data Table on Hematology - Market size and forecast 2023-2028 ($ billion)
• Exhibit 70: Chart on Hematology - Year-over-year growth 2023-2028 (%)
• Exhibit 71: Data Table on Hematology - Year-over-year growth 2023-2028 (%)
• 7.6 Critical care - Market size and forecast 2023-2028
• Exhibit 72: Chart on Critical care - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Data Table on Critical care - Market size and forecast 2023-2028 ($ billion)
• Exhibit 74: Chart on Critical care - Year-over-year growth 2023-2028 (%)
• Exhibit 75: Data Table on Critical care - Year-over-year growth 2023-2028 (%)
• 7.7 Others - Market size and forecast 2023-2028
• Exhibit 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 78: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 79: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.8 Market opportunity by Application
• Exhibit 80: Market opportunity by Application ($ billion)
• Exhibit 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 83: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 84: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 85: Chart on Geographic comparison
• Exhibit 86: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 115: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 116: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 117: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 118: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 125: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 127: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 128: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 129: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 130: Matrix on vendor position and classification
• 12.3 ADMA Biologics Inc.
• Exhibit 131: ADMA Biologics Inc. - Overview
• Exhibit 132: ADMA Biologics Inc. - Business segments
• Exhibit 133: ADMA Biologics Inc. - Key offerings
• Exhibit 134: ADMA Biologics Inc. - Segment focus
• 12.4 Bharat Serums and Vaccines Ltd.
• Exhibit 135: Bharat Serums and Vaccines Ltd. - Overview
• Exhibit 136: Bharat Serums and Vaccines Ltd. - Product / Service
• Exhibit 137: Bharat Serums and Vaccines Ltd. - Key offerings
• 12.5 CSL Ltd.
• Exhibit 138: CSL Ltd. - Overview
• Exhibit 139: CSL Ltd. - Business segments
• Exhibit 140: CSL Ltd. - Key offerings
• Exhibit 141: CSL Ltd. - Segment focus
• 12.6 Emergent BioSolutions Inc.
• Exhibit 142: Emergent BioSolutions Inc. - Overview
• Exhibit 143: Emergent BioSolutions Inc. - Product / Service
• Exhibit 144: Emergent BioSolutions Inc. - Key news
• Exhibit 145: Emergent BioSolutions Inc. - Key offerings
• 12.7 GC Biopharma corp.
• Exhibit 146: GC Biopharma corp. - Overview
• Exhibit 147: GC Biopharma corp. - Product / Service
• Exhibit 148: GC Biopharma corp. - Key offerings
• 12.8 Grifols SA
• Exhibit 149: Grifols SA - Overview
• Exhibit 150: Grifols SA - Business segments
• Exhibit 151: Grifols SA - Key offerings
• Exhibit 152: Grifols SA - Segment focus
• 12.9 Intas Pharmaceuticals Ltd.
• Exhibit 153: Intas Pharmaceuticals Ltd. - Overview
• Exhibit 154: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibit 155: Intas Pharmaceuticals Ltd. - Key offerings
• 12.10 Kedrion S.p.A
• Exhibit 156: Kedrion S.p.A - Overview
• Exhibit 157: Kedrion S.p.A - Product / Service
• Exhibit 158: Kedrion S.p.A - Key offerings
• 12.11 LFB SA
• Exhibit 159: LFB SA - Overview
• Exhibit 160: LFB SA - Product / Service
• Exhibit 161: LFB SA - Key offerings
• 12.12 Merck KGaA
• Exhibit 162: Merck KGaA - Overview
• Exhibit 163: Merck KGaA - Business segments
• Exhibit 164: Merck KGaA - Key news
• Exhibit 165: Merck KGaA - Key offerings
• Exhibit 166: Merck KGaA - Segment focus
• 12.13 Mitsubishi Chemical Group Corp.
• Exhibit 167: Mitsubishi Chemical Group Corp. - Overview
• Exhibit 168: Mitsubishi Chemical Group Corp. - Business segments
• Exhibit 169: Mitsubishi Chemical Group Corp. - Key offerings
• Exhibit 170: Mitsubishi Chemical Group Corp. - Segment focus
• 12.14 Octapharma AG
• Exhibit 171: Octapharma AG - Overview
• Exhibit 172: Octapharma AG - Product / Service
• Exhibit 173: Octapharma AG - Key offerings
• 12.15 Sanquin
• Exhibit 174: Sanquin - Overview
• Exhibit 175: Sanquin - Product / Service
• Exhibit 176: Sanquin - Key offerings
• 12.16 SK Inc.
• Exhibit 177: SK Inc. - Overview
• Exhibit 178: SK Inc. - Product / Service
• Exhibit 179: SK Inc. - Key offerings
• 12.17 Takeda Pharmaceutical Co. Ltd.
• Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 183: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 184: Inclusions checklist
• Exhibit 185: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 186: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 187: Research methodology
• Exhibit 188: Validation techniques employed for market sizing
• Exhibit 189: Information sources
• 13.5 List of abbreviations
• Exhibit 190: List of abbreviations